🔗 Share this article

Given that the United States continues making unprecedented adjustments to its vaccine guidelines, one figure has emerged unexpectedly: Høeg, a Danish American physician and epidemiologist who rose to prominence by casting doubt on COVID-19 shots throughout the global health crisis and has concentrated on potential deaths following COVID-19 immunization in her short time at the FDA.

Scheduled Changes to Pediatric Immunization Program

Agency leaders planned to reveal sweeping revisions to the childhood immunization program earlier this month, synchronizing the US with the Danish immunization schedule, sources say – a significant shift that would put the US at odds with many the global community with insufficient data for public health gain. This reveal has been postponed until the coming year.

Instead of Vinay Prasad, Dr. Høeg is set to present at the gathering. She was recently named acting director of the FDA’s drug evaluation center, the fifth individual to run the office this year.

A New Direction at the Agency

This interim role could signify a strengthened alliance between the pharmaceutical and biologics branches as Høeg and Prasad consolidate power at the regulatory agency – and it suggests a greater focus upon dismantling already-approved immunizations at the FDA.

Dr. Høeg has often pushed for halting certain pediatric shot schedules in the US in order to be more like Denmark's approach, a nation with nationalized medicine and a citizenry about the population of the state of Wisconsin.

In her initial public appearances, she has persisted in emphasizing on vaccines – usually the domain of Dr. Prasad, head of the FDA’s Center for Biologics Evaluation and Research (CBER) – as opposed to pharmaceutical oversight.

Concerns Over Qualifications

Høeg has little discernible background in medication creation, regulation or management, which has been customary for previous directors of the CBER. She has worked at the FDA as a senior adviser to the commissioner and CBER since March.

“It seems she lacks to have any of the qualifications” for overseeing the CDER, remarked Dr. Jonathan Howard. “She has not conducted a clinical trial. She lacks experience in managing a large organization. She lacks background in drug approvals.”

Past commissioners of the center would “be deeply familiar with laws and regulations and the science of medication creation”, noted a former acting FDA commissioner. “Frankly, she lacks the kind of background that former directors who led the center have had.”

CDER has an vast portfolio at the agency, she pointed out.

“Many people just zeroes in on the new drug program, but the generic program approves thousands of generic drugs. There is also a biosimilars division, over-the-counter program and so forth, and every single one must be managed,” Dr. Woodcock explained. “The area you neglect, that’s the thing that I always told people is going to bite you.”

Additionally, a significant administrative aspect to the role, which supervises over 5,000 staff members. “It’s a enormous management job, if you do it right,” Woodcock concluded.

Agency Reaction and Disputed Initiatives

In response to concerns about Høeg’s qualifications and whether this selection signifies increased cooperation among FDA leaders on vaccines, a spokesperson stated that the “questions stem from flawed presumptions”.

“Her resume is consistent with the responsibilities of her position,” the representative stated, noting the period Dr. Høeg spent counseling the FDA commissioner on “medication safety and oversight research, including predictive safety algorithms and vaccine surveillance”.

In her interim role, Høeg takes over the commissioner’s recently launched fast-track approval initiative, a disputed expedited medication authorization process that reportedly worried her preceding directors. “How are these medications being selected for this voucher program? Who is making the decisions?” Dr. Howard questioned. “There is a lot of secrecy going on at the agency right now.”

Overall, he said, “the Food and Drug Administration looks to be trending towards more relaxed rules of most medications, except for vaccines.”

Documented History on Immunizations

Regarding immunizations, Dr. Høeg has a more established, if problematic, past, Howard have noted. She released a analysis using non-validated volunteer-provided data to determine the incidence of heart inflammation after COVID-19 immunization. She consulted for the Florida top health official Dr. Joseph Ladapo, who allegedly have modified findings to imply COVID-19 vaccinations are more dangerous than they are.

Included in her “desired changes” for the incoming government included revising rules for new vaccines and discontinuing “non-essential” vaccines, she stated after the election on a audio program. At the agency, Høeg has according to sources suggested barring teenage boys from receiving Covid vaccinations.

“She’s an complete ideologue who starts off with her beliefs and works backwards to retrofit the data in a very misleading, fraudulent manner,” Dr. Howard argued.

Taking Control and a “Campaign of Retribution”

Dr. Høeg joined fellow skeptics, {like|